8-hydroxy-2--deoxyguanosine has been researched along with Carcinoma--Small-Cell* in 2 studies
1 trial(s) available for 8-hydroxy-2--deoxyguanosine and Carcinoma--Small-Cell
Article | Year |
---|---|
Biomarker evidence of DNA oxidation in lung cancer patients: association of urinary 8-hydroxy-2'-deoxyguanosine excretion with radiotherapy, chemotherapy, and response to treatment.
Ratios of urinary 8-hydroxy-2'-deoxyguanosine to urinary creatinine (8-OHdG/creatinine) have been considered as a good biological indicator of DNA oxidation. Urinary 8-OHdG/creatinine levels of lung cancer patients were evaluated by enzyme-linked immunosorbent assay using a monoclonal antibody N45.1 during radiotherapy and chemotherapy. An increase in urinary 8-OHdG/creatinine was found in non-small-cell carcinoma (non-SCC) patients during the course of radiotherapy. SCC patients showed higher levels of urinary 8-OHdG/creatinine than the controls. Furthermore, SCC patients with complete or partial response to the chemotherapy showed a significant decrease in urinary 8-OHdG/creatinine while patients with no change or progressive disease showed an increase. Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Aged; Aged, 80 and over; Biomarkers; Carcinoma, Small Cell; Creatinine; Cross-Sectional Studies; Deoxyguanosine; DNA; Female; Humans; Lung Neoplasms; Male; Middle Aged; Oxidation-Reduction; Smoking; Treatment Outcome | 1997 |
1 other study(ies) available for 8-hydroxy-2--deoxyguanosine and Carcinoma--Small-Cell
Article | Year |
---|---|
[Expressions of 8-OH-dG, k-ras, and p53 genes in pleural effusion cells and their clinical significances].
Oxidative DNA damage plays an important role in carcinogens-induced carcinogenesis. 8-hydoxy-2deoxy-guanosine (8-OH-dG), a biomarker of oxidative DNA damage, plays important roles in initiation, progression, and prognosis of lung cancer, and closely relates with mutations of k-ras and p53 genes in carcinogenesis of lung tissue. This study was to detect protein expressions of 8-OH-dG, k-ras, and p53 genes in lung cancer tissues, and to analyze their values in distinguished diagnosis of lung cancer.. Protein levels of 8-OH-dG, k-ras, and p53 in pleural effusion cells from 53 patients with lung cancer, and 53 patients with other benign lung diseases were detected by immunocytochemistry.. Positive rates of 8-OH-dG, k-ras, and p53 protein in cancer group were significantly higher than those in benign disease group [75.5% (40/53) vs. 15.1% (8/53), P < 0.01; 64.2% (34/53) vs. 3.8% (2/53), P < 0.01; and 69.8% (37/53) vs. 18.9% (10/53), P < 0.01; respectively]. Protein levels of 8-OH-dG, k-ras, and p53 protein in cancer group were 1.68+/-1.21, 1.32+/-1.06, and 1.57+/-1.15,respectively. Rank correlation analysis showed that protein expression of 8-OH-dG positively correlated with those of k-ras (RS=0.643, P < 0.01), and p53 (RS=0.827, P < 0.01)u protein expression of k-ras positively correlated with that of p53 (RS=0.897, P < 0.01).. Protein expressions of 8-OH-dG, k-ras, and p53 are up-regulated in pleural effusion cells of lung cancer, and have mutual relations. They may be used as reference markers in diagnosing and screening for lung cancer. Topics: 8-Hydroxy-2'-Deoxyguanosine; Adenocarcinoma; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Deoxyguanosine; Gene Expression Regulation, Neoplastic; Genes, p53; Genes, ras; Humans; Lung Neoplasms; Pleural Effusion, Malignant; ras Proteins; Tumor Suppressor Protein p53; Up-Regulation | 2005 |